Serial changes in metabolic dysfunction-associated steatotic liver disease after sleeve gastrectomy and their associations with abdominal adiposity: A prospective cohort study

Chung-Yi Yang,Jian-Han Chen,Chung-Yen Chen,Cheng-Yi Kao,Shiu-Feng Huang,Wen-Yu Chang,Hung-Pin Tu,Jee-Fu Huang,Ming-Lung Yu,Chi-Ming Tai
DOI: https://doi.org/10.1016/j.soard.2024.11.007
IF: 3.709
2024-11-30
Surgery for Obesity and Related Diseases
Abstract:Background Little is known about the associations between changes in hepatic steatosis and changes in abdominal adiposity after metabolic bariatric surgery. Objectives To evaluate the serial changes in hepatic steatosis and abdominal adiposity following sleeve gastrectomy (SG). Setting University hospital, Taiwan Methods In this prospective study, patients who underwent SG and intraoperative liver biopsy were enrolled. Magnetic resonance imaging (MRI) was performed to assess the liver fat fraction (LFF), visceral adipose tissue (VAT) area and subcutaneous adipose tissue (SAT) area. Liver fibrosis was assessed preoperatively via biopsy and the fibrosis-4 index (FIB-4) and postoperatively with the FIB-4. Results Seventy-six metabolic dysfunction-associated steatotic liver disease (MASLD) patients, including 67 pure MASLD patients and 9 MASLD patients with combined etiologies, were enrolled. LFF and visceral-to-subcutaneous fat ratio were associated with metabolic dysfunction-associated steatohepatitis, and VAT area was associated with significant fibrosis (≥ F2). Twelve months after SG, all MRI measurements significantly improved. The median LFF of pure MASLD patients decreased from 17.4% at baseline to 4.2% and 3.7% at the 6 th and 12 th postoperative months, respectively. Complete resolution of steatosis was achieved in 97.5% of patients at the 12 th postoperative months. Using %VAT and %SAT reductions at the 6 th postoperative month as references, LFF decreased more rapidly, with fold ratios of 1.3 and 1.8, respectively. Conclusions SG resulted in a significant decrease in hepatic steatosis and abdominal adiposity in patients with severe obesity, but hepatic steatosis improved faster than abdominal adiposity. Hepatic steatosis resolved in almost all patients 12 months after SG.
surgery
What problem does this paper attempt to address?